TrialRMD open2020

Long-term safety of tofacitinib up to 9.5 years: a comprehensive integrated analysis of the rheumatoid arthritis clinical development programme.

Stanley B Cohen et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.